Page 43 - Bivalent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a bivalent COVID booster vaccine, making it the first country in th

Fruit Bites for August 16-18 ... Apple Grower of the Year

In the intensive care unit, or even deaths. the uk's medicines and healthcare products regulatory agency approved it. drjune raine, the regulator's chief executive, called it "a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve." our health reporter explains more about what we know. all the vaccines used so far were designed against the original coronavirus that hit two years ago. this vaccine is designed against the original virus and the newer omicron variant of the virus. moderna tested it in 437 people and found in those people that it h...

This is outside source live from the bbc newsroom. welcome. our main story... the struggle for ordinary afghans a year after the fall of the western government and the return to rule under the taliban. kenya's deputy president, william ruto, has been declared the winner of last week's closely fought presidential election. here in the uk, a new covid booster vaccine has been approved. it's the first to specifically target the covid variant, omicron, as well as the original virus. it's made by moderna. here's its uk medical director. so, this new bivalent vaccine will aim to prevent against infe...

Originalform of the all been designed against the original form of the virus which emerged in wuhan in china at the end of 2019. they still give strong protection against severe illness, but they are not very good at preventing you getting a milder covid infection, that is because covid—19 has mutated substantially, with several new variants that can dodge some of our immune defences. moderna's new vaccine targets the wuhan strain and are now dominant 0micron variant, so it is a jewel or bivalentjab. in trials, it produced higher antibody responses among volunteers, with mostly mild side—e...